Enabling timely comparative effectiveness research: head-to-head analysis of GLP-1s for weight loss

This webinar will highlight results of a real-world GLP-1 comparative effectiveness study and the impact of timely and representative RWD in assessing performance of new therapies.

GLP-1 drugs have garnered extensive media coverage and celebrity endorsements over the past year for their ability to drive weight loss. With more than 73% of adults in the US considered overweight or obese, millions taking GLP-1s, and head-to-head randomized clinical trials still being more than a year away, understanding the real-world effectiveness of these drugs is crucial. Truveta Research recently conducted a ground-breaking comparative effectiveness study using timely real-world data.

Your details

By submitting this form you are agreeing to our Terms & Conditions and Privacy Policy, and agree to receiving relevant emails from The Evidence Base about the latest news and editorial features.

Terms & Conditions

I agree to receive third party emails to keep me informed of relevant products and services relevant to my industry.

I agree for my registration data to be transferred to the sponsoring organization (Truveta).

Subscribing to

Confirm sign-up

What you will learn:

Learn how type 2 diabetes-labeled semaglutide (Ozempic) and tirzepatide (Mounjaro) stack up in terms of weight loss potential in real-world settings
Explore the role of RWE in gauging real-world effectiveness of pharmaceuticals, particularly in populations underrepresented in clinical trials
Discover the power of timely and representative RWD to drive product innovation and accelerate medical breakthroughs

Speakers:

Tricia Rodriguez, PhD, MPH
Principal Applied Scientist, Truveta

Tricia Rodriguez, Principal Applied Scientist at Truveta, specializes in using real-world data (RWD) to study patient outcomes. With over a decade of experience in RWD, she's conducted research and published in a variety of disease areas, including diabetes, colorectal cancer, cystic fibrosis, HIV, and eating disorders. Tricia holds a PhD in Health Economics and Outcomes Research and a Master’s in Public Health, both from the University of Washington. Before Truveta, she held research positions at Verily Life Sciences and the University of Washington.

Michael Simonov, MD
Chief Medical Officer and VP of Product Management, Truveta

Michael Simonov, MD, Chief Medical Officer and VP of Product Management at Truveta, is an internist and clinical informaticist who’s primary career focus has been leveraging electronic health record data for improving human health. At Truveta, he leads the product and clinical informatics teams to ensure Truveta Data and Studio provide highest-quality data to fuel clinical research. Prior to this role, he served as medical information officer for research at the Yale New Haven Health System and a clinical and EHR researcher in the Yale Department of Medicine.

Moderator:

Laura Dormer
Editor, The Evidence Base
Editor in Chief, Journal of Comparative Effectiveness Research
Editorial Director, Becaris Publishing

Share this webinar